BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35032213)

  • 1. Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement study.
    Kim HY; Lee YJ; Chang W; Cho J; Park JH; Lee JC; Kim J; Hwang JH; Kim YH
    Eur Radiol; 2022 Jun; 32(6):3799-3807. PubMed ID: 35032213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
    Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
    Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
    Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation.
    Park JH; Yoon YS; Lee S; Kim HY; Han HS; Lee JS; Chang W; Kim H; Na HY; Han S; Lee KH
    Korean J Radiol; 2022 Mar; 23(3):322-332. PubMed ID: 35029083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability.
    Jang JK; Choi SJ; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
    J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1025-1034. PubMed ID: 35658103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.
    Park S; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Hong SB; Park SH
    Eur Radiol; 2021 May; 31(5):3383-3393. PubMed ID: 33123793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
    Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
    Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting resection margin status of pancreatic neuroendocrine tumors on CT: performance of NCCN resectability criteria.
    Kim DH; Kim B; Chung DJ; Kim KA; Lee SL; Choi MH; Kim H; Rha SE
    Br J Radiol; 2023 Dec; 96(1152):20230503. PubMed ID: 37750830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
    Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
    Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
    Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
    Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up CT.
    Park SJ; Kim JH; Joo I; Han JK
    Abdom Radiol (NY); 2021 Oct; 46(10):4765-4778. PubMed ID: 34085090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement.
    Joo I; Lee JM; Lee ES; Son JY; Lee DH; Ahn SJ; Chang W; Lee SM; Kang HJ; Yang HK
    Radiology; 2019 Nov; 293(2):343-349. PubMed ID: 31502935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
    Allen VB; Gurusamy KS; Takwoingi Y; Kalia A; Davidson BR
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009323. PubMed ID: 24272022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability.
    Ahmed SA; Mourad AF; Hassan RA; Ibrahim MAE; Soliman A; Aboeleuon E; Elbadee OMA; Hetta HF; Jabir MA
    Abdom Radiol (NY); 2021 Jan; 46(1):280-289. PubMed ID: 32488556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
    Gillen S; Schuster T; Meyer Zum Büschenfelde C; Friess H; Kleeff J
    PLoS Med; 2010 Apr; 7(4):e1000267. PubMed ID: 20422030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
    Allen VB; Gurusamy KS; Takwoingi Y; Kalia A; Davidson BR
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009323. PubMed ID: 27383694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
    Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
    Ann Oncol; 2017 Sep; 28(9):2067-2076. PubMed ID: 28407088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis.
    Kim BR; Kim JH; Ahn SJ; Joo I; Choi SY; Park SJ; Han JK
    Eur Radiol; 2019 Jan; 29(1):362-372. PubMed ID: 29931561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.